The enigma of the metabolic fate of circulating erythropoietin (Epo) in view of the pharmacokinetics of the recombinant drugs rhEpo and NESP

Wolfgang Jelkmann*

*Corresponding author for this work
100 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The enigma of the metabolic fate of circulating erythropoietin (Epo) in view of the pharmacokinetics of the recombinant drugs rhEpo and NESP'. Together they form a unique fingerprint.

Medicine & Life Sciences